Branch, K. R. H., Lam, C. S. P., Islam, S., Del Prato, S., Lopes, R. D., Pratley, R., … Gerstein, H. C. (2025). Effect of Efpeglenatide on Heart Failure Outcomes: A Participant-Level Exploratory Analysis of the Randomized AMPLITUDE-O Trial. Diabetes Care, 48(8), e95–e96. https://doi.org/10.2337/dc24-2629

Branch, Kelley R. H., Carolyn S. P. Lam, Shofiqul Islam, Stefano Del Prato, Renato D. Lopes, Richard Pratley, Julio Rosenstock, Naveed Sattar, and Hertzel C. Gerstein. “Effect of Efpeglenatide on Heart Failure Outcomes: A Participant-Level Exploratory Analysis of the Randomized AMPLITUDE-O Trial.” Diabetes Care 48, no. 8 (August 1, 2025): e95–96. https://doi.org/10.2337/dc24-2629.

Branch KRH, Lam CSP, Islam S, Del Prato S, Lopes RD, Pratley R, et al. Effect of Efpeglenatide on Heart Failure Outcomes: A Participant-Level Exploratory Analysis of the Randomized AMPLITUDE-O Trial. Diabetes Care. 2025 Aug 1;48(8):e95–6.

Branch, Kelley R. H., et al. “Effect of Efpeglenatide on Heart Failure Outcomes: A Participant-Level Exploratory Analysis of the Randomized AMPLITUDE-O Trial.” Diabetes Care, vol. 48, no. 8, Aug. 2025, pp. e95–96. Pubmed, doi:10.2337/dc24-2629.

Branch KRH, Lam CSP, Islam S, Del Prato S, Lopes RD, Pratley R, Rosenstock J, Sattar N, Gerstein HC. Effect of Efpeglenatide on Heart Failure Outcomes: A Participant-Level Exploratory Analysis of the Randomized AMPLITUDE-O Trial. Diabetes Care. 2025 Aug 1;48(8):e95–e96.